oncology
Icon changes course on Victorian lease after ACCC probe
Icon Group has withdrawn plans to lease part of a Victorian hospital for a new radiation oncology clinic, putting an end to an ACCC review Oncology pharmacy specialist Icon Group …
More evidence for charting
Call for more widespread adoption of medication charting in cancer units following study findings Use of Partnered Pharmacist Medication Charting (PPMC) in oncology units is associated with significantly lower rates …
‘Cancer changed everything’
Early career pharmacist and cancer survivor Jessica Chapman-Goetz is determined to inspire fellow pharmacists to provide supportive oncology care It was a sunny summer’s day in December 2015 and Jessica …
What’s different about biosimilars?
AJP host Miranda talks to the highly knowledgeable and engaging UK oncologist, Dr Paul Cornes, about biosimilars: what they are, and key learnings from his international experience for the retail …
Oncology pharmacist shines at Telstra Business Woman awards
Oncology pharmacist Julie Adams has been named 2016 Telstra Western Australian Business Woman of the Year. Adams was recognised for her business, chemo@home, which offers patients the convenience and flexibility …
Slade to purchase Fresenius Kabi oncology compounding business
Slade Pharmacy Services has entered into agreements with Fresenius Kabi to purchase its Oncology Compounding Business in Australia. This includes all the TGA-licenced compounding facilities in Queensland, NSW and Victoria. …
Action needed to cut prostate cancer deaths
Prostate cancer is the fourth most common cause of male deaths and more must be done improve survival rates, by detecting it early. Prostate cancer has the dubious distinction of being fourth most …